intellectual property Invitae, OptraHealth Resolve Chatbot Patent Dispute OptraHealth will license its automated genetic test result retrieval and return process to Invitae, while both companies continue to offer their own products. Senate Bill Proposes Bringing Back Patents on Genes Premium Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics. European Patent Office Upholds ERS Genomics-Held CRISPR Patent The CRISPR-Cas9-related patent, EPO Patent No. 3,401,400, had been opposed on grounds that it lacked novelty and inventiveness. OptraHealth Sues Invitae for Infringement of AI-Based Chatbot Patent OptraHealth claims that Invitae has violated its patent since the latter added results return capabilities to its Gia chatbot in February 2021. Takara Bio USA Wins European Patent Challenge Filed by Jumpcode Genomics Over NGS Library Prep The patent, granted in 2019, is part of Takara's portfolio covering methods used in RNA-sequencing library prep kits containing ZapR technology. Feb 8, 2022 MilliporeSigma Licenses Sigma-Aldrich CRISPR IP to Agbio Firm BetterSeeds Jan 20, 2022 Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable Oct 29, 2021 Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute Aug 30, 2021 Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit May 10, 2021 Invitae Sues Natera Alleging Infringement of Patent on DNA Sequencing Assembly Technique Feb 1, 2021 US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents Apr 23, 2020 USPTO Board Denies Illumina Request to Review BGI Patent Oct 15, 2019 Dart-seq Leads New Methods to Sequence Transcriptome Methylation Patterns Premium Jun 25, 2019 CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference Jun 17, 2019 Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics May 6, 2019 Hong Kong Startup Licenses Nasopharyngeal Cancer Early Detection Technology From Grail Apr 22, 2019 Enzo, Hologic, Grifols Settle Patent Dispute Apr 2, 2019 Ag-Bio Startup Amfora Licenses CRISPR IP From Corteva, Broad Institute Dec 10, 2018 Agilent Granted Motion to Amend Complaint for Lawsuit Against Twist Bioscience Oct 9, 2018 ERS Genomics Licenses CRISPR-Cas9 Genome Editing IP to GenAhead Bio Sep 18, 2018 Thermo Fisher Licenses CRISPR Patents From Broad Institute, ERS Genomics Feb 28, 2018 Personal Genome Diagnostics Licenses Tumor Mutation Burden IP From MSKCC Jan 24, 2018 Premaitha to Appeal UK Patent Infringement Ruling in Case Against Illumina Jan 23, 2018 Thermo Fisher's Life Technologies Granted Request to Arbitrate Fraud Dispute With Cornell Jan 17, 2018 Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.